drugset / Trial / NCT04704947
Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis
RandomizedParallel-groupOpen-labelTreatment
Summary
Clinical study evaluating selective or nonselective beta blockers use and fracture risk in patients with primary osteoporosis
Timeline
- Start
- 2017-10-01
- Primary completion
- 2030-10-01
- Completion
- 2030-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bisoprolol | Other / unclassified | 5 mg | — |
| Subject | Propranolol | Small molecule | 10 mg | — |
| Background | Alendronic Acid | Small molecule | 70 mg | — |